These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14738535)

  • 1. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus.
    Evans AV; Palmer RA; Hawk JL
    Photodermatol Photoimmunol Photomed; 2004 Feb; 20(1):59-61. PubMed ID: 14738535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of chronic actinic dermatitis treated with topical tacrolimus.
    Baldo A; Prizio E; Mansueto G; Somma P; Monfrecola G
    J Dermatolog Treat; 2005; 16(4):245-8. PubMed ID: 16249148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia.
    Ogawa Y; Adachi A; Tomita Y
    J Dermatol; 2003 Nov; 30(11):805-9. PubMed ID: 14684938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic actinic dermatitis: treatment with topical tacrolimus (two cases)].
    Alquier-Bouffard A; Da Costa CM; Roger H; Franck F; Taïeb A; Souteyrand P; D'incan M
    Ann Dermatol Venereol; 2007; 134(6-7):555-8. PubMed ID: 17657183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of nodular actinic reticuloid with tacrolimus ointment.
    Gröne D; Kunz M; Zimmermann R; Gross G
    Dermatology; 2006; 212(4):377-80. PubMed ID: 16707890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus 0.1% ointment applied under occlusion using cling film clears chronic actinic dermatitis resistant to systemic treatment.
    Bhari N; Gupta S
    Int J Dermatol; 2017 Jun; 56(6):e139-e141. PubMed ID: 28239836
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study.
    Ma Y; Lu Z
    J Dermatolog Treat; 2010 May; 21(3):171-7. PubMed ID: 20394493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic actinic dermatitis with tacrolimus ointment.
    Uetsu N; Okamoto H; Fujii K; Doi R; Horio T
    J Am Acad Dermatol; 2002 Dec; 47(6):881-4. PubMed ID: 12451373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic actinic dermatitis with tacrolimus ointment.
    McCall CO
    J Am Acad Dermatol; 2003 Oct; 49(4):775; author reply 775-6. PubMed ID: 14512946
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of chronic actinic dermatitis with topical pimecrolimus.
    Larangeira de Almeida H
    Int J Dermatol; 2005 Apr; 44(4):343-4. PubMed ID: 15811093
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe refractory chronic actinic dermatitis successfully treated with tacrolimus ointment.
    Abe R; Shimizu T; Tsuji A; Matsumura T; Shimizu H
    Br J Dermatol; 2002 Dec; 147(6):1273-5. PubMed ID: 12452891
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD; Goldman D; Ide T; Yoo SH
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topical tacrolimus in chronic actinic dermatitis].
    Girault PY; Boye T; Veran Y
    Ann Dermatol Venereol; 2008 Oct; 135(10):688-90. PubMed ID: 18929923
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of circulating T-cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects.
    Hamada T; Aoyama Y; Shirafuji Y; Iwatsuki K
    Int J Dermatol; 2017 May; 56(5):540-546. PubMed ID: 28176301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G; Sułowicz W; Paczek L
    Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.
    García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR
    Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.